NO Synthase Inhibition Increases Aldosterone in Humans

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

NO synthase inhibition increases aldosterone in humans.

To test the hypothesis that NO influences aldosterone production in humans, we examined the effect of N(G)-nitro-L-arginine methyl ester (L-NAME) on aldosterone concentrations in the presence and absence of the NO precursor L-arginine (3 g TID) and the angiotensin-converting enzyme inhibitor ramipril (10 mg QD). Ten normal subjects were given L-NAME (66 microg/kg per min for 30 minutes) or vehi...

متن کامل

Aldosterone synthase inhibition in humans.

Aldosterone synthase (CYP11B2) inhibition has emerged as a new option for the treatment of hypertension, heart failure and renal disorders, in addition to mineralocorticoid receptor (MR) blockade. The aim is to decrease aldosterone concentrations in both plasma and tissues, thereby decreasing MR-dependent and MR-independent effects in the cardiac, vascular and renal target organs. LCI699 was th...

متن کامل

Specific Aldosterone Synthase Inhibition

We have come to appreciate the many physiological and pathophysiological functions of adrenal steroid hormones in health and disease and the benefits and adverse effects of therapeutic manipulations. Glucocorticoids are an indispensable component in the treatment of inflammatory conditions. Blockade of the mineralocorticoid receptor (MR) with spironolactone is a long-established diuretic therap...

متن کامل

Endothelial NO synthase target of aldosterone.

Endothelial NO Synthase Target of Aldosterone Print ISSN: 0194-911X. Online ISSN: 1524-4563 Copyright © 2006 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Hypertension doi: 10.1161/01.HYP.0000226055.65364.8e 2006;48:27-28; originally published online June 5, 2006; Hypertension. http://hyper.ahajourn...

متن کامل

NO-synthase inhibition in sepsis.

Thromb Haemost 2006; 95: 591–2 Despite major advances and novel therapeutic approaches in intensive care medicine, sepsis is still a major burden of modern medicine and the leading cause of death in non-coronary intensive care units (1). Sepsis represents a complex disease state with distinctive activation of the inflammation cascade and the coagulation system, resulting in pervasive macroand m...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Hypertension

سال: 2004

ISSN: 0194-911X,1524-4563

DOI: 10.1161/01.hyp.0000143852.48258.f1